BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 3319603)

  • 1. Nonsecreting pituitary tumors.
    Klibanski A
    Endocrinol Metab Clin North Am; 1987 Sep; 16(3):793-804. PubMed ID: 3319603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotroph cell pituitary adenomas.
    Snyder PJ
    Endocrinol Metab Clin North Am; 1987 Sep; 16(3):755-64. PubMed ID: 3319601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function correlations of human pituitary gonadotroph adenomas in vitro.
    Asa SL; Gerrie BM; Kovacs K; Horvath E; Singer W; Killinger DW; Smyth HS
    Lab Invest; 1988 Apr; 58(4):403-10. PubMed ID: 2451766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically nonfunctioning pituitary adenomas.
    Snyder PJ
    Endocrinol Metab Clin North Am; 1993 Mar; 22(1):163-75. PubMed ID: 8449186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of gonadotroph adenomas in women.
    Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ
    N Engl J Med; 1991 Feb; 324(9):589-94. PubMed ID: 1899470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine.
    Kwekkeboom DJ; de Jong FH; Lamberts SW
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1128-35. PubMed ID: 2542356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin regulation of glycoprotein hormone and free subunit secretion in clinically nonfunctioning and somatotroph adenomas in vitro.
    Klibanski A; Alexander JM; Bikkal HA; Hsu DW; Swearingen B; Zervas NT
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1248-55. PubMed ID: 1720125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone beta subunit response to thyrotropin-releasing hormone.
    Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1352-5. PubMed ID: 8077332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-functioning pituitary adenomas.
    Chanson P; Brochier S
    J Endocrinol Invest; 2005; 28(11 Suppl International):93-9. PubMed ID: 16625856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of nonfunctioning pituitary adenomas.
    Sassolas G; Trouillas J; Treluyer C; Perrin G
    Acta Endocrinol (Copenh); 1993 Jul; 129 Suppl 1():21-6. PubMed ID: 8103955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotroph cell adenomas of the pituitary.
    Snyder PJ
    Endocr Rev; 1985; 6(4):552-63. PubMed ID: 2416559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of pituitary adenomas.
    Leavens ME; McCutcheon IF; Samaan NA
    Oncology (Williston Park); 1992 Jun; 6(6):69-79; discussion 79-80. PubMed ID: 1319190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral vectors efficiently transduce human gonadotroph and somatotroph adenomas in vitro. Targeted expression of transgene by pituitary hormone promoters.
    Roche C; Zamora AJ; Taïeb D; Lavaque E; Rasolonjanahary R; Dufour H; Bagnis C; Enjalbert A; Barlier A
    J Endocrinol; 2004 Oct; 183(1):217-33. PubMed ID: 15525589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric pituitary adenoma: a series of 42 patients.
    Pandey P; Ojha BK; Mahapatra AK
    J Clin Neurosci; 2005 Feb; 12(2):124-7. PubMed ID: 15749410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropinomas.
    Chaidarun SS; Klibanski A
    Semin Reprod Med; 2002 Nov; 20(4):339-48. PubMed ID: 12536357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotroph adenoma with secondary hypersecretion of testosterone.
    Chamoun R; Layfield L; Couldwell WT
    World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro.
    Pawlikowski M; Lawnicka H; Pisarek H; Kunert-Radek J; Radek M; Culler MD
    J Physiol Pharmacol; 2007 Mar; 58(1):179-88. PubMed ID: 17440235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotroph adenoma of the pituitary gland: a clinicopathologic analysis of 100 cases.
    Young WF; Scheithauer BW; Kovacs KT; Horvath E; Davis DH; Randall RV
    Mayo Clin Proc; 1996 Jul; 71(7):649-56. PubMed ID: 8656706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypophyseal dysfunction and tumors].
    Bürgi U; Seiler R
    Ther Umsch; 1992 Mar; 49(3):136-41. PubMed ID: 1585268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.